NIBEC has been growing earnings at an average annual rate of 16.4%, while the Biotechs industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 20.5% per year. NIBEC's return on equity is 15.5%, and it has net margins of 22.6%.
How NIBEC makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KOSDAQ:A138610 Revenue, expenses and earnings (KRW Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
32,343
7,298
7,207
5,613
31 Dec 25
32,719
4,642
8,753
5,613
30 Sep 25
32,960
3,137
10,452
4,074
30 Jun 25
33,577
-2,437
15,088
4,074
31 Mar 25
23,739
-11,068
13,524
4,074
31 Dec 24
24,550
-9,327
12,413
4,074
30 Sep 24
22,812
-7,848
16,730
0
30 Jun 24
19,407
-4,843
11,853
0
31 Mar 24
17,578
-5,890
11,142
0
31 Dec 23
15,704
-6,284
10,490
0
30 Sep 23
16,213
-11,672
6,230
5,361
30 Jun 23
17,493
-8,157
5,258
5,361
31 Mar 23
18,878
-5,163
7,157
4,402
31 Dec 22
21,670
-3,766
12,390
0
30 Sep 22
20,077
-678
9,192
806
30 Jun 22
20,776
-846
8,052
1,492
31 Mar 22
18,766
-3,340
5,222
3,735
31 Dec 21
13,625
-5,740
4,612
3,333
30 Sep 21
12,682
-4,419
3,903
3,356
30 Jun 21
9,383
-5,519
3,320
2,937
31 Mar 21
7,225
-4,834
2,596
1,957
31 Dec 20
6,357
-3,638
2,411
1,535
30 Sep 20
6,775
-2,314
2,087
1,354
30 Jun 20
7,971
-1,830
2,482
1,358
31 Mar 20
8,949
-2,235
2,667
1,646
31 Dec 19
9,287
-2,727
2,682
1,683
30 Sep 19
7,803
-3,589
2,951
1,640
30 Jun 19
6,664
-4,022
2,588
1,453
31 Mar 19
5,717
-4,021
2,550
1,347
31 Dec 18
5,208
-4,146
2,395
1,204
30 Sep 18
5,085
-4,556
2,373
1,134
30 Jun 18
5,326
-4,127
2,237
1,065
31 Mar 18
5,223
-3,406
2,018
644
31 Dec 17
6,303
-2,568
2,210
641
30 Sep 17
6,219
-1,683
2,399
228
30 Jun 17
5,890
-2,383
2,724
292
31 Mar 17
5,849
-2,280
2,834
256
31 Dec 16
4,804
-3,027
2,848
252
30 Sep 16
4,589
-2,823
2,532
169
30 Jun 16
4,600
-2,354
2,413
108
31 Mar 16
4,645
-2,586
2,418
120
31 Dec 15
4,174
-2,426
2,248
114
30 Sep 15
3,915
-2,317
2,238
90
Quality Earnings: A138610 has high quality earnings.
Growing Profit Margin: A138610 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A138610 has become profitable over the past 5 years, growing earnings by 16.4% per year.
Accelerating Growth: A138610 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A138610 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (22.6%).
Return on Equity
High ROE: A138610's Return on Equity (15.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/08/04 11:24
End of Day Share Price
2026/08/04 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NIBEC Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.